SAMMI SMITH: Open Payments
NPI 1013982693 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,923 in 91 payments from 25 companies in 2025. Trend: 2023 $1,677 · 2024 $1,574 · 2025 $1,923
Food & beverage: $1,899Education: $24
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $397 |
| Dexcom, Inc. | 9 | $177 |
| Medtronic, Inc. | 6 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $117 |
| Amgen Inc. | 6 | $107 |
| Corcept Therapeutics | 5 | $96 |
| ABBVIE INC. | 4 | $85 |
| SANOFI-AVENTIS U.S. LLC | 4 | $78 |
| Radius Health, Inc. | 3 | $78 |
| Tandem Diabetes Care, Inc. | 3 | $66 |
Products named: Ozempic, Dexcom G6 Transmitter, MINIMED 780G, Kerendia, Korlym, TEPEZZA, TZIELD, Tymlos.
Industry payments across LA — which companies pay providers there.
